Clinical Data for 483 Hyperuricemia Patients with Vitamin D and CVD Metrics

483 patient records from a cross-sectional study at the Second Affiliated Hospital of Harbin Medical University between September 2023 and November 2024. The dataset includes clinical data for patients with hyperuricemia, stratified by serum vitamin D levels, and contains metrics related to cardiovascular disease prevalence and severity. Author Huan Lei published the data on figshare under a CC-BY-4.0 license.

Use Cases

• Train logistic regression models to predict CVD risk based on vitamin D levels and age.
• Perform correlation analysis between vitamin D (25(OH)D) and clinical markers like glycated hemoglobin, total cholesterol, and triacylglycerol.
• Analyze the association between vitamin D deficiency and coronary artery stenosis severity using the Gensini score.
• Stratify patient risk groups based on serum 25-hydroxyvitamin D concentrations (deficiency, insufficiency, sufficiency).

Strengths

• Dataset contains 483 patient records with a clear temporal coverage from 09/2023 to我们发现 11/2024.
• Clinical stratification is explicitly defined into three vitamin D status groups with specific sample counts (n=150, 226, 107).
• Key statistical results, including correlation coefficients and odds ratios, are provided in the description, suggesting derived variables are present.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is from a single hospital in Harbin, which may reflect geographic or institutional bias.

Provenance

Source

Second Affiliated Hospital of Harbin Medical University.

Collection Method

Cross-sectional study using clinical data from admitted patients.

Time Range

01/09/2023 to 01/11/2024.

Freshness

Last updated 2026-04-03 17:45:57; freshness should be verified.

Geography

Harbin, China.